Alprostadil

Pediatric
  • TRADE NAMES: Caverject (Pfizer); Edex (Schwarz); Lyple; Minprog; Muse (Vivus); Palux; Prostin VR (Pfizer); Prostine VR; Prostivas
  • INDICATIONS: Impotence; to maintain patent ductus arteriosus
  • SYNONYM: PGE; prostaglandin E1
  • CLASS: Prostaglandin
  • HALF-LIFE: 5–10 minutes
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Acebutolol, Alfuzosin, Captopril, Cilazapril, Enalapril, Fosinopril, Irbesartan, Lisinopril, Olmesartan, Quinapril, Ramipril

PREGNANCY CATEGORY: D
not indicated for use in women

APNEA (in neonates with congenital heart defects)

See full prescribing information for complete boxed warning.

Our database has 50 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
HAIR
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
NEUROMUSCULAR/SKELETAL
GASTROINTESTINAL/HEPATIC
RESPIRATORY
GENITOURINARY
LOCAL
OTHER


Page last updated 12/12/2016

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric